T1	Participants 65 114	systemic inflammatory response to cardiac surgery
T2	Participants 690 758	Patients scheduled for coronary artery bypass graft surgery with CPB
T3	Participants 818 845	n = 22) or placebo (n = 21)
T4	Participants 1845 1880	patients undergoing cardiac surgery
